Biotech Bull

Getting thru, just like the rest of us.

[Biotech Bull @sthode9]

@ManaByte there are 8 billion things on that earth that conflict with each other everyday. makes zero sense. incredible pic

[Biotech Bull @sthode9]

@WatcherBiotech It's all the final legal, I think

[Biotech Bull @sthode9]

@JMRothberg @alifmunim @ButterflyNetInc @NYSE @Hyperfine What are your thoughts on the NGS coverage arguments? Do you think the evidence suggests their proposal is no longer justified?

[Biotech Bull @sthode9]

@jmack6999 @spittinchiclets Good few weeks!!

[Biotech Bull @sthode9]

@BizNasty2point0 https://t.co/SYdzpm1zMX biz see how real leaders speak after a game. Not "let's keep it going boys" maybe you can push the Sabres yoot to learn from this...

[Biotech Bull @sthode9]

@Mishi_2210 16

[Biotech Bull @sthode9]

@jmack6999 @spittinchiclets Hopefully with Parity in the league they can do it with 32-20.

[Biotech Bull @sthode9]

@BioValues Market waiting on this too it seems. Good data, not enough. Currently. Nice to see this news.

[Biotech Bull @sthode9]

@BioValues They claim they were in the term sheet stage. So presumably in DD phase currently. Hopefully.

[Biotech Bull @sthode9]

Well, first time I have seen $ESPR across the CNBC ticker! Is that a sign?

[Biotech Bull @sthode9]

@MACROVET888 @Hoshko2 EURO Margins of 15% * 400M * (1.15) Euro to USD is effectively $50-60M to Bottom line*25 = $1.25 B alone in value... This company could produce 15-30 cents next year. $2B Mkt Cap is not out of question. Patience...

[Biotech Bull @sthode9]

@Blueeee_Jay @junior__white @EsperionInc Institutions are still made of people that don't take risk until a stock is over $1B generally. I don't live this raise, but I don't hate it either. I worry about the Milestone payments. Contested again?

[Biotech Bull @sthode9]

@curtmelonopoly @Blueeee_Jay You need to check share counts. They have changed substantially through your technicals from years ago.

[Biotech Bull @sthode9]

@Bbrc424864Bbrc

[Biotech Bull @sthode9]

@Bbrc424864Bbrc

[Biotech Bull @sthode9]

@MACROVET888 @Biobeats99 I did 30% over next 5 years and terminal growth of 9% and get $21. It's a cool tool as you can go back and forth. But, I am in the $11 camp one year out. and $15 2 years out. Only time will tell.

[Biotech Bull @sthode9]

@MACROVET888 @Biobeats99 In Grok? In Grok the assumptions are relatively conservative. But let's type the exact same prompt and See "Create A DCF for ESPR Stock using your default assumptions"

[Biotech Bull @sthode9]

@MACROVET888 All options seem to now be in place for mgmt as well. This was a far more confident, calm CEO

[Biotech Bull @sthode9]

@AndriiMart1 @MACROVET888 3 times 2026 revenue would be a fair price currently. Each additional ANDA settlement push this to 4 times. So $340*1.4*3 multiple. Target $7.50 ish (Actually Should be priced at $7.5 now more or less) Lots' of upside. HC also sandbagging operating CF.